Particularly, in the case of cancer datasets, we show that MAYA can detect cell type specific modes of pathway activation for both the microenvironment and tumor cells, defining common expression programs across patients, in line with recently identified tumor “meta-programs”15. This evidence concerns the gene MNX1-AS1 and neoplasm.